SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Rocket One (RKTO) — Dec 2, 2025

Rocket One Inc.
Date: Dec. 2, 2025 · CIK: 0001711786 · Accession: 0001213900-25-117325

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-291566

Date
December 2, 2025
Author
Robb Knie
Form
CORRESP
Company
Rocket One Inc.

Letter

Hoth Therapeutics, Inc.

1177 Avenue of the Americas, 5th Floor, Suite

New York, New York 10036

December 2, 2025

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Doris Gama

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-291566

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, December 4, 2025, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
 1
 filename1.htm

 Hoth
Therapeutics, Inc.

 1177 Avenue of the Americas, 5th Floor, Suite
5066

 New York, New York 10036

 December 2, 2025

 VIA EDGAR

 United States Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

 Attention: Doris Gama

 Re:
 Hoth Therapeutics, Inc.

 Registration Statement on Form S-3

 File No. 333-291566

 Ladies and Gentlemen:

 Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the "Company")
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Thursday, December 4, 2025, or as soon thereafter as possible.

 Please notify Nazia Khan of
Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.

 HOTH THERAPEUTICS, INC.

 By:
 /s/ Robb Knie

 Name:
 Robb Knie

 Title:
 Chief Executive Officer